JCVVX | VIVIX | JCVVX / VIVIX | |
Total Expense Ratio | 0.84 | 0.04 | 2,100% |
Annual Report Gross Expense Ratio | 0.85 | 0.04 | 2,125% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 2.747 | 2.452 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 598M | 189B | 0% |
Annual Yield % from dividends | 2.93 | 2.29 | 128% |
Returns for 1 year | -27.40 | 8.01 | -342% |
Returns for 3 years | -29.20 | 32.19 | -91% |
Returns for 5 years | 7.56 | 72.56 | 10% |
Returns for 10 years | 0.25 | 103.54 | 0% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EKSRX | 6.02 | -0.02 | -0.33% |
Allspring Diversified Income Bldr R6 | |||
RYCFX | 40.37 | -0.38 | -0.93% |
Rydex Biotechnology C | |||
PREIX | 157.52 | -1.77 | -1.11% |
T. Rowe Price Equity Index 500 | |||
DNSMX | 21.13 | -0.32 | -1.49% |
Driehaus Small Cap Growth Institutional | |||
JGSMX | 20.88 | -0.39 | -1.83% |
JPMorgan Small Cap Growth R6 |